GlassScriptPhysician profile
Steven Adler
NPI 1316064363
$7,800.12
in general payments reported to CMS, 2019-2025
34 companies · $533 in 2025
The $533 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,603 · 2022: $2,599 · 2023: $659 · 2024: $406 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,597.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $1,388.69 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $1,056.53 | 2021 | |
| Boston Scientific Corporation | $874.85 | 2021-2025 | General - Vascular Intervention, Superion Indirect Decompression System |
| Nevro Corp. | $832.23 | 2021-2024 | Senza |
| Biodelivery Sciences International, INC. | $562.53 | 2021 | |
| Abbvie INC. | $443.56 | 2021-2024 | Qulipta, Ubrelvy, Botox |
| Amgen INC. | $340.46 | 2021-2022 | |
| Abbott Laboratories | $312.08 | 2021-2025 | Proclaim |
| Globus Medical, INC. | $223.12 | 2025 | Senza, Omnia |
| Allergan, INC. | $210.32 | 2021-2022 | |
| Vertos Medical, INC. | $199.88 | 2022-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $184.55 | 2021-2024 | Xtampza, Belbuca |
| Nalu Medical, INC. | $159.25 | 2023-2024 | Nalu Neurostimulation System |
| Saol Therapeutics INC. | $123.97 | 2021 | |
| Medtronic, INC. | $114.03 | 2023-2024 | Intellis Adaptivestim |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $104.55 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.41 | 2021-2024 | Relistor |
| Pacira Therapeutics, INC. | $87.89 | 2021 | |
| Electronic Waveform Lab, INC. | $87.33 | 2021-2024 | |
| Tersera Therapeutics LLC | $47.58 | 2022 | |
| Ibsa Pharma INC. | $46.42 | 2024-2025 | Licart, Tirosint, Flector |
| Almatica Pharma LLC | $43.04 | 2021 | |
| Bioventus LLC | $41.94 | 2022 | |
| Scilex Pharmaceuticals INC. | $30.74 | 2021-2022 | |
| Grt US Holding, INC. | $29.18 | 2021 | |
| Avanos Medical | $26.31 | 2023 | Generator |
| Spr Therapeutics, INC | $24.22 | 2021 | |
| Saluda Medical Americas, INC. | $21.46 | 2023-2024 | Evoke, Evoke Scs |
| Mckesson Medical-Surgical Minnesota Supply, INC | $19.65 | 2024 | |
| Virtus Pharmaceuticals LLC | $17.66 | 2021 | |
| Hikma Pharmaceuticals USA | $14.45 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.64 | 2022 | |
| Alfasigma USA, INC. | $13.17 | 2021 | |
| Trevena, INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.